Monograph Title | Section | Source Publication | Page Number | Errata Post Date Sort ascending | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
FLUTICASONE PROPIONATE NASAL SPRAY | OTHER COMPONENTS/Content of Phenylethyl Alcohol | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Transfer 1.0 g of the Nasal Spray to a 50-mL volumetric flask. Add about 40 mL of Diluent, and sonicate for 10 min until the supernatant is clear. Use the clear supernatant for analysis. to: Transfer 1.0 g of the… Read More |
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change Uniformity of Dosage Units 〈905〉 Procedure for content uniformity to: Uniformity of Dosage Units 〈905〉: Meets the requirements Procedure for content uniformity, chewable tablets only AND In … Read More |
ACARBOSE TABLETS | IDENTIFICATION/B. | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change The spectrum obtained from the Sample solution shows IR maxima in the regions of 3500–3200, 2950–2890, 1653–1633, and 1070–1000 cm–1. to: The spectrum obtained from the sample preparation shows IR maxima in the regions of 3500–3200… Read More |
POLYETHYLENE GLYCOL 12 CETOSTEARYL ETHER | IDENTIFICATION | USPNF Online | Online | 28-Apr-2023 | 1-Aug-2023 | NA | NA | Change: B. Test for Hydroxyl Group: to: B. Hydroxyl Value: AND In D./Analysis: Change Dissolve or disperse the Sample in alcohol. to: Dissolve or disperse the … Read More |
VIGABATRIN TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Analysis: Change CS = concentration of USP Vigabatrin Related Compound A in the Standard solution to: CS = concentration of USP Vigabatrin Related Compound A RS in the Standard solution |
ROSEMARY LEAF DRY AQUEOUS EXTRACT | COMPOSITION/Content of Rosmarinic Acid | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Standard solution B: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, AND In Sample solution: Change … Read More |
BUPIVACAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Chromatographic system/Column: Change 4-mm × 30-cm; packing L1 to: 3.9-mm × 30-cm; packing L1 AND In System suitability: Change [Note—The relative retention times for bupivacaine hydrochloride and dibutyl phthalate are… Read More |
ESCITALOPRAM TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Buffer: Change Adjust with 1 N sodium hydroxide VS to a pH of 5.2. to: Adjust with 1 N sodium hydroxide to a pH of 5.2. |
<1042> CELL BANKING PRACTICES FOR RECOMBINANT BIOLOGICS | 5. CELL BANK CHARACTERIZATION | USPNF Online | Online | 31-Mar-2023 | 1-May-2023 | NA | NA | In Table 4: Change In vitro assayd,e + + +f to: In vitro assayd,e + −f + |
CALCIUM LACTATE | CHEMICAL INFORMATION | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Calcium lactate (1:2) hydrate to: Calcium lactate hydrate AND Change Calcium lactate (1:2) pentahydrate to: Calcium lactate pentahydrate |
THYROID | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Chromatographic system: Change Column: 4.6-cm × 25-cm; packing L1 to: Column: 4.6-mm × 25-cm; packing L1 |
PRAZOSIN HYDROCHLORIDE CAPSULES | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) CU = nominal concentration of prazosin in the Sample solution (µg/mL) Mr1… Read More |
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE TABLETS | IMPURITIES/Limit of 2-Methylbenzhydrol | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Standard solution: Change 7.5 µg/mL of USP 2-Methylbenzhydrol RS in methanol to: 7.5 µg/mL of USP Methylbenzhydrol RS in methanol AND In Analysis: Change CS = concentration of USP 2-Methylbenzhydrol RS in the… Read More |
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION | Identification | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Proceed as directed in the Identification test under Erythromycin Ethylsuccinate Oral Suspension, beginning with “Prepare a Standard solution.” to: Prepare a Standard solution of USP Erythromycin Ethylsuccinate RS in methanol… Read More |
<209> LOW MOLECULAR WEIGHT HEPARIN MOLECULAR WEIGHT DETERMINATIONS | PROCEDURE | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In footnote 1 in Molecular Weight Measurements of Low Molecular Weight Heparins by Gel Permeation Chromatography/Chromatographic system/Columns/Analytical: Change guard column TSK SWXL 6-mm × 4-mm; to: guard column TSK… Read More |
LEVORPHANOL TARTRATE TABLETS | PERFORMANCE TESTS/Uniformity of Dosage Units 〈905〉 | USPNF Online | Online | 31-Mar-2023 | 1-Aug-2023 | NA | NA | In Sample solution: Change Nominally about 80 ug/mL of levorphanol tartrate in Diluent prepared as follows. to: Nominally about 80 µg/mL of levorphanol tartrate in Diluent prepared as follows. |
THYROID TABLETS | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Chromatographic system: Change Column: 4.6-cm × 25-cm; packing L1 to: Column: 4.6-mm × 25-cm; packing L1 |
PRAZOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) to: CS = concentration of USP Prazosin Hydrochloride RS in the Standard… Read More |
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change USP 2-Methylbenzhydrol RS to: USP Methylbenzhydrol RS |
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION | Assay | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Constitute Erythromycin Ethylsuccinate for Oral Suspension as directed in the labeling, and proceed as directed in the Assay under Erythromycin Ethylsuccinate Oral Suspension. to: Constitute Erythromycin Ethylsuccinate for Oral… Read More |
DEXTRATES | ASSAY/Dextrose Equivalent | USPNF Online | Online | 31-Mar-2023 | 1-May-2023 | NA | NA | In Analysis: Change rA = peak response of each saccharide degree of polymerization (DP1–DP3) in the Sample solution (If any peaks of DP4 and above are observed in the sample, take the summation… Read More |
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Norethindrone Acetate RS (mg/mL) or USP Ethinyl Estradiol RS (ug/mL) in the Standard solution to: CS = concentration of USP Norethindrone Acetate… Read More |
ERYTHROMYCIN DELAYED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 1: Change Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents, Indicators, and Solutions—Buffer Solutions) to: Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents,… Read More |
SOTALOL HYDROCHLORIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In Analysis: Change Calculate the percentage of any unspecified impurities in the portion of Sotalol Hydrochloride taken: Result = (rU/rS) × (CS/CU) × 100 r… Read More |
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION | Assay for lidocaine hydrochloride | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine and Epinephrine Injection. to: Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine… Read More |
TRIETHYL CITRATE | ASSAY/Procedure | USPNF Online | Online | 24-Feb-2023 | 1-May-2023 | NA | NA | In System suitability/Suitability requirements/Tailing factor: Change NMT 1.5 for the triethyl citrate to trimethyl citrate peaks to: NMT 1.5 for the triethyl citrate and trimethyl citrate peaks |
METAPROTERENOL SULFATE TABLETS | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
GLYCYL-L-TYROSINE | IMPURITIES/Related Compounds | USPNF Online | Online | 24-Feb-2023 | 1-Jun-2023 | NA | NA | In Buffer solution: Change Dissolve 6.84 g of potassium phosphate in 1000 mL of water. to: Dissolve 6.84 g of monobasic potassium phosphate in 1000 mL of water. |
MIRTAZAPINE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change 10-ketomirtazpine to: 10-ketomirtazapine AND In Table 1: Change 1-Ketomirtazpinec to: 1-Ketomirtazapinec |
METAPROTERENOL SULFATE ORAL SOLUTION | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
MESO-ZEAXANTHIN PREPARATION | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
MESO-ZEAXANTHIN | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
POTASSIUM GLUCONATE ORAL SOLUTION | SPECIFIC TESTS | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change Alcohol Determination 〈611〉, Method II—Distillation Method: to: Alcohol Determination 〈611〉, Method I—Distillation Method: |
Methyl Acetate | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change CAS RN®: 74-20-9. to: CAS RN®: 79-20-9. |
MESO-ZEAXANTHIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-Zeaxanthin to: (3R,3′S)-Zeaxanthin |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | COMPOSITION/Procedure 4: Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin AND In Analysis: Change (3R,3′S … Read More |
ISOBUTYL ALCOHOL | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change rS = sum of all the peaks except those each of which with an area less than 0.1 times the area of the major peak from the Reference solution to: rT = sum of all the peaks except those… Read More |
FLUTICASONE PROPIONATE NASAL SPRAY | IMPURITIES/Organic Impurities | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Samples: System suitability solution, Identification solution, and Sample solution to: Samples: Identification solution and Sample solution |
MESO-ZEAXANTHIN PREPARATION | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
MESO-ZEAXANTHIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
<251> LEAD | PROCEDURES/Procedure 1: Chemical Method | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In Analysis: Change Add to the acid solution 5.0 mL of Standard dithizone solution and 4 mL of Ammonia cyanide solution, to: Add to the acid solution 5.0 mL of Standard dithizone solution and 4 mL of Ammonium cyanide… Read More |
METARAMINOL BITARTRATE | SPECIFIC TESTS/Content of Tartaric Acid | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = {[(VS−VB) × N × F]/2 × W} × 100 to: Result = {[(VS−VB) × N × F]/(2 × W)} × 100 |
MESO-ZEAXANTHIN | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
CHLOROPROCAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Sample solution: Change Transfer about 100 mg of chloroprocaine hydrochloride to a 100-mL volumetric flask, dissolve in 40 mL of methanol, and dilute with water to volume. to: Transfer a volume of Injection, equivalent to about 100 mg of… Read More |
POLYETHYLENE GLYCOL STANDARDS WITH MOLECULAR WEIGHTS OF 1000, 2000, 3000, 4000, AND 6000 DALTONS (G/MOL) | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change CAS RN®: 25332-68-3. to: CAS RN®: 25322-68-3. |
DEXAMETHASONE SODIUM PHOSPHATE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = (rU/rS) × (CS/CU) × (Mr1/Mr22) × 100 to: Result = (rU/r… Read More |
MESO-ZEAXANTHIN PREPARATION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
<251> LEAD | REQUIREMENTS FOR PROCEDURE VALIDATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change • Precision Repeatability to: • Precision |
METARAMINOL BITARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP Metaraminol Enantiomer RS: Change 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol. C9H13NO2 167.21 to: 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate. C9H… Read More |